Impax Laboratories Inc. (IPXL) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Net income before noncontrolling interest: -179.34M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Net income before noncontrolling interest: -179.34M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q1 EPS of $0.52, $0.03 better than the analyst estimate of $0.49. Revenue for the quarter came in at $123.3 million versus the consensus estimate of $163.74 million.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
